4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-017555
Chief Medical Officer gave up 7,940 shares (to pay taxes)
- Chief Medical Officer acquired 28,897 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon David N. Chief Medical Officer | 2021-03-01 | Option exercise | +20,600 | 108,135 | D | ||
| Gordon David N. Chief Medical Officer | 2021-03-01 | Shares withheld for taxes | −5,660 | $24.06 | $136,180 | 102,475 | D |
| Gordon David N. Chief Medical Officer | 2021-03-02 | Option exercise | +8,297 | 110,772 | D | ||
| Gordon David N. Chief Medical Officer | 2021-03-02 | Shares withheld for taxes | −2,280 | $23.25 | $53,010 | 108,492 | D |
| Derivatives | |||||||
| Gordon David N. Chief Medical Officer | 2021-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +99,500 | 99,500 | D | ||
| Gordon David N. Chief Medical Officer | 2021-03-01 | Grant or award · Restricted stock units | +28,400 | 28,400 | D | ||
| Gordon David N. Chief Medical Officer | 2021-03-01 | Option exercise · Restricted stock units | −20,600 | 41,200 | D | ||
| Gordon David N. Chief Medical Officer | 2021-03-02 | Option exercise · Restricted stock units | −8,297 | 24,892 | D | ||
Loading xslF345X03/doc4.xml…